News

In turbulent markets, investors in 2025 are seeking both stable pillars and strong return opportunities. Traditional ...
Company delivers 8% revenue growth, expanded margins, and maintains fiscal year 2025 guidance Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and ...